Hackensack Meridian Well being presents an entire vary of medical providers, progressive analysis and life-enhancing care. The community has 18 hospitals and greater than 500 affected person care places. The community’s notable distinctions embody having the one #1 ranked grownup and youngsters’s hospitals in New Jersey, as ranked by U.S. Information & World Report, 2023-24. Hackensack College Medical Heart is nationally-ranked by U.S. Information & World Report in six specialties.
“We’re proud to collaborate with Compass Pathways, a number one biotechnology firm aiming to create actual change for folks struggling with among the most difficult-to-treat psychological well being circumstances,” mentioned Robert C. Garrett, FACHE, CEO of Hackensack Meridian Well being . “Our community’s management in psychological well being and intensive expertise in treating melancholy in scientific observe will inform how new psychological well being therapies could also be accessed by sufferers sooner or later.”
“Our collaboration with Hackensack Meridian Well being will assist us perceive how investigational COMP360 psilocybin remedy, if authorized, could possibly be delivered to sufferers, and represents one other vital milestone in our mission to offer higher remedy choices for individuals who urgently want them,” mentioned Kabir Nath, CEO of Compass Pathways. “As one of many largest, most complete and really built-in well being care networks within the US, with a robust mission to enhance scientific outcomes and remodel healthcare supply, HMH is a good collaboration accomplice for Compass.”
About Compass Pathways
Compass Pathways plc (Nasdaq: CMPS) is a biotechnology firm devoted to accelerating affected person entry to evidence-based innovation in psychological well being. Our focus is on enhancing the lives of those that are struggling with psychological well being challenges and who are usually not helped by present therapies. We’re pioneering the event of a brand new mannequin of psilocybin remedy, wherein our proprietary formulation of artificial psilocybin, COMP360, is run along side psychological assist. COMP360 has been designated a Breakthrough Remedy by the U.S. Meals and Drug Administration (FDA) and has acquired Modern Licensing and Entry Pathway (ILAP) designation within the UK for treatment-resistant melancholy (TRD).
We now have commenced a section 3 scientific program of COMP360 psilocybin remedy in TRD, the most important randomized, managed, double-blind psilocybin remedy scientific program ever performed. Beforehand, we accomplished a section 2b research with prime line information exhibiting a statistically vital (p
Compass is headquartered in London, UK, with places of work in New York and San Francisco in the USA. Our imaginative and prescient is a world of psychological wellbeing. www.compasspathways.com .
About Hackensack Meridian Well being
Hackensack Meridian Well being is a number one not-for-profit well being care group that’s the largest, most complete and really built-in well being care community in New Jersey, providing an entire vary of medical providers, progressive analysis and life-enhancing care. The community has 18 hospitals and greater than 500 affected person care places, which embody ambulatory care facilities, surgical procedure facilities, dwelling well being providers, long-term care and assisted dwelling communities, ambulance providers, lifesaving air medical transportation, rehabilitation facilities, pressing care facilities, doctor observe places, and a health and wellness middle. With greater than 35,000 crew members and seven,000 physicians, Hackensack Meridian Well being is a distinguished chief in well being care philanthropy and dedicated to the well being and well-being of communities all through New Jersey.
The community’s notable distinctions embody having the one #1 ranked grownup and youngsters’s hospitals in New Jersey, as ranked by U.S. Information & World Report, 2023-24. Hackensack College Medical Heart is nationally-ranked by U.S. Information & World Report in six specialties. To be taught extra, go to www.hackensackmeridianhealth.org .
Availability of different details about Compass Pathways
Buyers and others ought to word that we talk with our buyers and the general public utilizing our web site ( www.compasspathways.com ), our investor relations web site ( ir.compasspathways.com ), and on social media (LinkedIn), together with however not restricted to investor shows and investor truth sheets, US Securities and Alternate Fee filings, press releases, public convention calls and webcasts. The data that we put up on these channels and web sites could possibly be deemed to be materials info. Consequently, we encourage buyers, the media, and others fascinated by us to overview the knowledge that’s posted on these channels, together with the investor relations web site, regularly. This checklist of channels could also be up to date every now and then on our investor relations web site and will embody further social media channels. The contents of our web site or these channels, or every other web site that could be accessed from our web site or these channels, shall not be deemed included by reference in any submitting underneath the Securities Act of 1933.
Ahead-looking statements
Compass Pathways:
This press launch accommodates forward-looking statements inside the which means of the Non-public Securities Litigation Reform Act of 1995, as amended. In some circumstances, forward-looking statements will be recognized by terminology equivalent to “might”, “will”, “might”, “would”, “anticipate”, “intend”, “plan”, “anticipate”, “consider”, “potential” and “proceed” and “ongoing,” or the destructive of those phrases or different comparable terminology, though not all forward-looking statements comprise these phrases. Ahead-looking statements embody specific or implied statements referring to, amongst different issues, the security or efficacy of investigational COMP360 psilocybin remedy as a remedy for melancholy, post-traumatic stress dysfunction or anorexia nervosa, the potential for the pivotal section 3 program or different trials to assist regulatory filings and approvals, Compass’s enterprise technique and objectives, Compass’s plans, expectations and skill to realize its objectives associated to this analysis collaboration settlement; Compass’s capacity to proceed to advance its analysis, acquire regulatory approval or develop plans to carry COMP360 psilocybin remedy to sufferers, and Compass’s expectations concerning the advantages of its investigational COMP360 psilocybin remedy. The forward-looking statements on this press launch are neither guarantees nor ensures, and you shouldn’t place undue reliance on these forward-looking statements as a result of they contain recognized and unknown dangers, uncertainties, and different elements, a lot of that are past Compass’s management and which might trigger precise outcomes, ranges of exercise, efficiency or achievements to vary materially from these expressed or implied by these forward-looking statements.
These dangers, uncertainties, and different elements embody, amongst others: scientific growth is prolonged and outcomes are unsure, and due to this fact Compass’s scientific trials could also be delayed or terminated; the outcomes early-stage scientific trials of investigational COMP360 psilocybin remedy will not be predictive of the outcomes of later stage scientific trials; Compass’s efforts to acquire advertising approval from the relevant regulatory authorities in any jurisdiction for COMP360 or any of future product candidates could also be unsuccessful, and Compass’s efforts to acquire protection and reimbursement for its investigational COMP360 psilocybin remedy, if authorized, could also be unsuccessful; the danger that this analysis collaboration with Hackensack Meridian Well being won’t proceed or won’t achieve success; and people dangers and uncertainties described underneath the heading “Danger Components” in Compass’s most up-to-date annual report on Kind 10-Okay or quarterly report on Kind 10-Q and in different experiences we have now filed with the U.S. Securities and Alternate Fee (“SEC”) , which can be found on the SEC’s web site at www.sec.gov . Besides as required by regulation, Compass disclaims any intention or duty for updating or revising any forward-looking statements contained on this press launch within the occasion of recent info, future developments or in any other case. These forward-looking statements are primarily based on Compass’s present expectations and communicate solely as of the date hereof.
Enquiries
Compass Pathways:
Media: Amy Lawrence, media@compasspathways.com , +44 7813 777 919
Buyers: Stephen Schultz, stephen.schultz@compasspathways.com , +1 401 290 7324
Hackensack Meridian Well being :
Media: Jessica Nussman, jessica.nussman@hmhn.org , 551-237-0984; Elizabeth Llorente, Elizabeth.Llorente@hmhn.org , 646-573-8487
